Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Women's perspectives on counseling about risks for medication-induced birth defects.

Santucci AK, Gold MA, Akers AY, Borrero S, Schwarz EB.

Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):64-9. doi: 10.1002/bdra.20618.


Perspectives of primary care clinicians on teratogenic risk counseling.

Schwarz EB, Santucci A, Borrero S, Akers AY, Nikolajski C, Gold MA.

Birth Defects Res A Clin Mol Teratol. 2009 Oct;85(10):858-63. doi: 10.1002/bdra.20599.


Clinical decision support to promote safe prescribing to women of reproductive age: a cluster-randomized trial.

Schwarz EB, Parisi SM, Handler SM, Koren G, Cohen ED, Shevchik GJ, Fischer GS.

J Gen Intern Med. 2012 Jul;27(7):831-8. doi: 10.1007/s11606-012-1991-y.


Counseling about medication-induced birth defects with clinical decision support in primary care.

Schwarz EB, Parisi SM, Handler SM, Koren G, Shevchik G, Fischer GS.

J Womens Health (Larchmt). 2013 Oct;22(10):817-24. doi: 10.1089/jwh.2013.4262. Epub 2013 Aug 9.


Women's perceptions of discussions about gestational weight gain with health care providers during pregnancy and postpartum: a qualitative study.

Nikolopoulos H, Mayan M, MacIsaac J, Miller T, Bell RC.

BMC Pregnancy Childbirth. 2017 Mar 24;17(1):97. doi: 10.1186/s12884-017-1257-0.


Provision of potentially teratogenic medications to female veterans of childbearing age.

Schwarz EB, Longo LS, Zhao X, Stone RA, Cunningham F, Good CB.

Med Care. 2010 Sep;48(9):834-42. doi: 10.1097/MLR.0b013e3181e57946.


Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers.

Eisenberg DL, Stika C, Desai A, Baker D, Yost KJ.

J Gen Intern Med. 2010 Apr;25(4):291-7. doi: 10.1007/s11606-009-1215-2. Epub 2010 Jan 20.


Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.

Bhakta J, Bainbridge J, Borgelt L.

Epilepsy Behav. 2015 Nov;52(Pt A):212-7. doi: 10.1016/j.yebeh.2015.08.004. Epub 2015 Nov 6.


Women's preconceptional health and use of health services: implications for preconception care.

Hillemeier MM, Weisman CS, Chase GA, Dyer AM, Shaffer ML.

Health Serv Res. 2008 Feb;43(1 Pt 1):54-75. doi: 10.1111/j.1475-6773.2007.00741.x.


Prescription of teratogenic medications in United States ambulatory practices.

Schwarz EB, Maselli J, Norton M, Gonzales R.

Am J Med. 2005 Nov;118(11):1240-9.


Counseling of female veterans about risks of medication-induced birth defects.

Schwarz EB, Mattocks K, Brandt C, Borrero S, Zephyrin LC, Bathulapalli H, Haskell S.

J Gen Intern Med. 2013 Jul;28 Suppl 2:S598-603. doi: 10.1007/s11606-012-2240-0.


Core state preconception health indicators - pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009.

Robbins CL, Zapata LB, Farr SL, Kroelinger CD, Morrow B, Ahluwalia I, D'Angelo DV, Barradas D, Cox S, Goodman D, Williams L, Grigorescu V, Barfield WD; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2014 Apr 25;63(3):1-62.


The clinical content of preconception care: the use of medications and supplements among women of reproductive age.

Dunlop AL, Gardiner PM, Shellhaas CS, Menard MK, McDiarmid MA.

Am J Obstet Gynecol. 2008 Dec;199(6 Suppl 2):S367-72. doi: 10.1016/j.ajog.2008.07.065.


Women's experiences with isotretinoin risk reduction counseling.

Werner CA, Papic MJ, Ferris LK, Lee JK, Borrero S, Prevost N, Schwarz EB.

JAMA Dermatol. 2014 Apr;150(4):366-71. doi: 10.1001/jamadermatol.2013.6862.


Women's perceived control of their birth outcomes in the Central Pennsylvania Women's Health Study: implications for the use of preconception care.

Weisman CS, Hillemeier MM, Chase GA, Misra DP, Chuang CH, Parrott R, Dyer AM.

Womens Health Issues. 2008 Jan-Feb;18(1):17-25. Epub 2007 Oct 22.


Are primary care residents adequately prepared to care for women of reproductive age?

Conway T, Hu TC, Mason E, Mueller C.

Fam Plann Perspect. 1995 Mar-Apr;27(2):66-70.


Change in women's knowledge of general and personal preconception health risks following targeted brief counseling in publicly funded primary care settings.

Dunlop AL, Logue KM, Thorne C, Badal HJ.

Am J Health Promot. 2013 Jan-Feb;27(3 Suppl):S50-7. doi: 10.4278/ajhp.120116-QUAN-39.


"They told me to leave": how health care providers address intimate partner violence.

Morse DS, Lafleur R, Fogarty CT, Mittal M, Cerulli C.

J Am Board Fam Med. 2012 May-Jun;25(3):333-42. doi: 10.3122/jabfm.2012.03.110193.


Human teratogens update 2011: can we ensure safety during pregnancy?

Rasmussen SA.

Birth Defects Res A Clin Mol Teratol. 2012 Mar;94(3):123-8. doi: 10.1002/bdra.22887. Epub 2012 Feb 13. Review.


Patient and provider perspectives on, an online contraceptive information tool, in a low income, racially diverse clinic population.

Gressel GM, Lundsberg LS, Illuzzi JL, Danton CM, Sheth SS, Xu X, Gariepy A.

Contraception. 2014 Dec;90(6):588-93. doi: 10.1016/j.contraception.2014.07.010. Epub 2014 Jul 25.


Supplemental Content

Support Center